SPONSOR
Astellas Pharma Global Development, Inc.
Total Trials
3
Recruiting
3
Phases
Phase 3
Conditions studied: Chronic Kidney DiseaseRenal AnemiaUrothelial CancerUrinary Bladder NeoplasmsGeographic AtrophyMacular Degeneration
Astellas Pharma Global Development, Inc. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Chronic Kidney Disease, Renal Anemia, Urothelial Cancer, Urinary Bladder Neoplasms.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Astellas Pharma Global Development, Inc.
How many clinical trials has Astellas Pharma Global Development, Inc. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Astellas Pharma Global Development, Inc., of which 3 are actively recruiting participants. These trials cover conditions including Chronic Kidney Disease, Renal Anemia, Urothelial Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Astellas Pharma Global Development, Inc. research focus on?
Astellas Pharma Global Development, Inc. clinical trials span Chronic Kidney Disease, Renal Anemia, Urothelial Cancer, Urinary Bladder Neoplasms, Geographic Atrophy, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Astellas Pharma Global Development, Inc. clinical trial?
To participate in a Astellas Pharma Global Development, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Astellas Pharma Global Development, Inc. trials with current recruitment status updated daily.
Clinical Trials by Astellas Pharma Global Development, Inc.
NCT05970172 Phase 3
Recruiting
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Chronic Kidney Disease
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Urothelial Cancer
NCT06779773
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology